Literature DB >> 20428445

Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces the vasoconstrictive response.

Y Maeda1, U Ikeda, M Shimpo, S Ishibashi, T Takizawa, J Monahan, K Ozawa, K Shimada.   

Abstract

BACKGROUND: Adeno-associated virus (AAV) has a number of attractive features for gene therapy including the ability to transduce nondividing cells and long term transgene expression.
OBJECTIVE: To investigate whether the endothelial constitutive nitric oxide synthase (ecNOS) gene can be efficiently introduced into rat aortic segments using AAV vectors and thereby modulate the vasoconstrictive response. ANIMALS AND METHODS: Excised rat aortas were incubated with medium containing ecNOS-expressing AAV vectors (AAV-ecNOS). Expression of ecNOS in the aortic segments was evaluated by immunohistochemical staining. The isometric tension of the aortic segments transduced with AAV-ecNOS was measured.
RESULTS: Adventitial cells in rat aortic segments were efficiently transduced with AAV-ecNOS. The vasoconstrictive response induced by 30 mmol/L K(+) was enhanced in endothelium-denuded aortic segments compared with intact aortic segments. However, in endothelium-denuded aortic segments transduced with AAV-ecNOS, the enhancement of the vasoconstrictive response disappeared. This effect induced by ecNOS gene transfer was abolished in the presence of the nitric oxide synthase inhibitor N(G)-monomethyl-l-arginine acetate.
CONCLUSIONS: These results show that ecNOS gene transfer using AAV vectors abolishes the pathological enhancement of the vasoconstrictive response in endothelium-denuded aortic segments.

Entities:  

Keywords:  Endothelium; Gene transfer; Nitric oxide; Vasoconstriction

Year:  2001        PMID: 20428445      PMCID: PMC2858966     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  38 in total

1.  Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors.

Authors:  E C Svensson; D J Marshall; K Woodard; H Lin; F Jiang; L Chu; J M Leiden
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

2.  VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

Authors:  M L Springer; A S Chen; P E Kraft; M Bednarski; H M Blau
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

3.  Expression and function of recombinant endothelial nitric oxide synthase gene in canine basilar artery.

Authors:  A F Chen; T O'Brien; M Tsutsui; H Kinoshita; V J Pompili; T B Crotty; D J Spector; Z S Katusic
Journal:  Circ Res       Date:  1997-03       Impact factor: 17.367

4.  Gene transfer into vascular cells using adeno-associated virus (AAV) vectors.

Authors:  Y Maeda; U Ikeda; Y Ogasawara; M Urabe; T Takizawa; T Saito; P Colosi; G Kurtzman; K Shimada; K Ozawa
Journal:  Cardiovasc Res       Date:  1997-09       Impact factor: 10.787

5.  Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats.

Authors:  S P Janssens; K D Bloch; Z Nong; R D Gerard; P Zoldhelyi; D Collen
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Adventitial gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries alters vascular reactivity.

Authors:  I J Kullo; G Mozes; R S Schwartz; P Gloviczki; T B Crotty; D A Barber; Z S Katusic; T O'Brien
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

7.  Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

Authors:  P D Kessler; G M Podsakoff; X Chen; S A McQuiston; P C Colosi; L A Matelis; G J Kurtzman; B J Byrne
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  Adeno-associated virus vectors for vascular gene delivery.

Authors:  C M Lynch; P S Hara; J C Leonard; J K Williams; R H Dean; R L Geary
Journal:  Circ Res       Date:  1997-04       Impact factor: 17.367

9.  VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo.

Authors:  J Mühlhauser; M J Merrill; R Pili; H Maeda; M Bacic; B Bewig; A Passaniti; N A Edwards; R G Crystal; M C Capogrossi
Journal:  Circ Res       Date:  1995-12       Impact factor: 17.367

10.  Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.

Authors:  C A Mack; S R Patel; E A Schwarz; P Zanzonico; R T Hahn; A Ilercil; R B Devereux; S J Goldsmith; T F Christian; T A Sanborn; I Kovesdi; N Hackett; O W Isom; R G Crystal; T K Rosengart
Journal:  J Thorac Cardiovasc Surg       Date:  1998-01       Impact factor: 6.439

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.